Detalhe da pesquisa
1.
Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease.
Circulation
; 145(17): 1312-1323, 2022 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35249370
2.
Oral versus Intravenous Antibiotics for Bone and Joint Infection.
N Engl J Med
; 380(5): 425-436, 2019 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30699315
3.
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.
BMC Med
; 20(1): 23, 2022 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35022047
4.
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force.
Value Health
; 25(1): 10-31, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35031088
5.
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations.
Value Health
; 25(1): 3-9, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35031096
6.
Healing the past, reimagining the present, investing in the future: What should be the role of race as a proxy covariate in health economics informed health care policy?
Health Econ
; 31(10): 2115-2119, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35929585
7.
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.
BMC Public Health
; 22(1): 179, 2022 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35081920
8.
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.
BMC Health Serv Res
; 22(1): 114, 2022 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35081957
9.
Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.
Int J Technol Assess Health Care
; 38(1): e13, 2022 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35007499
10.
Estimating (quality-adjusted) life-year losses associated with deaths: With application to COVID-19.
Health Econ
; 30(3): 699-707, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33368853
11.
SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer.
Br J Cancer
; 119(11): 1332-1338, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30420616
12.
External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting.
Value Health
; 20(3): 397-403, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28292484
13.
Cost-Effectiveness Model for Chemoimmunotherapy Options in Patients with Previously Untreated Chronic Lymphocytic Leukemia Unsuitable for Full-Dose Fludarabine-Based Therapy.
Value Health
; 19(4): 374-82, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27325329
14.
Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?
Value Health
; 19(6): 800-810, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27712708
15.
Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failure.
Am Heart J
; 170(5): 951-60, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26542504
16.
Economic Evaluation of Cinacalcet in the United States: The EVOLVE Trial.
Value Health
; 18(8): 1079-87, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26686794
17.
Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic review.
PLoS Med
; 11(5): e1001645, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24824338
18.
Questionnaire to assess relevance and credibility of modeling studies for informing health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report.
Value Health
; 17(2): 174-82, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24636375
19.
Projecting long-term graft and patient survival after transplantation.
Value Health
; 17(2): 254-60, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24636384
20.
Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenarios.
Value Health
; 17(5): 525-36, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25128045